PubMed

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.

Diabetes Care. 1987 Nov-Dec;10(6):71-8.PMID: 3123184 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

Groop L, Wåhlin-Boll E, Groop PH, Tötterman KJ, Melander A, Tolppanen EM, Fyhrqvist F.

Eur J Clin Pharmacol. 1985;28(6):697-704.PMID: 3933984 [PubMed - indexed for MEDLINE]Related articles

An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.

Jaber LA, Wenzloff NJ, Komanicky P, Antal EJ.

J Clin Pharmacol. 1990 Feb;30(2):181-8.PMID: 2107214 [PubMed - indexed for MEDLINE]Related articles

Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.

Simonson DC, Kourides IA, Feinglos M, Shamoon H, Fischette CT.

Diabetes Care. 1997 Apr;20(4):597-606.PMID: 9096986 [PubMed - indexed for MEDLINE]Related articles

Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.

Lev JD, Zeidler A, Kumar D.

Diabetes Care. 1987 Nov-Dec;10(6):679-82.PMID: 3123183 [PubMed - indexed for MEDLINE]Related articles

Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.

Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S.

Diabetes Care. 1994 Jan;17(1):45-9.PMID: 8112188 [PubMed - indexed for MEDLINE]Related articles

Benefits and risks with glyburide and glipizide in elderly NIDDM patients.

Brodows RG.

Diabetes Care. 1992 Jan;15(1):75-80.PMID: 1737544 [PubMed - indexed for MEDLINE]Related articles

Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

Osei K, O'Dorisio TM, Falko JM.

Am J Med. 1984 Dec;77(6):1002-9.PMID: 6439036 [PubMed - indexed for MEDLINE]Related articles

Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.

Simpson HC, Sturley R, Stirling CA, Reckless JP.

Diabet Med. 1990 Feb;7(2):143-7.PMID: 2137755 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.

Kitabchi AE, Kaminska E, Fisher JN, Sherman A, Pitts K, Bush A, Bryer-Ash M.

Am J Med Sci. 2000 Mar;319(3):143-8.PMID: 10746824 [PubMed - indexed for MEDLINE]Related articles

Effects of short-term insulin therapy upon therapeutic response to glipizide.

Schwartz SL, Fischer JS, Kipnes MS, Boyle M.

Am J Med. 1987 Sep 18;83(3A):22-30.PMID: 3307403 [PubMed - indexed for MEDLINE]Related articles

A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.

Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, Merante D.

Acta Diabetol. 1999 Jun;36(1-2):61-5.PMID: 10436254 [PubMed - indexed for MEDLINE]Related articles

A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.

JAMA. 1998 Jan 14;279(2):137-43.PMID: 9440664 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.

Kilo C.

Clin Ther. 1988;10(3):294-302.PMID: 3152586 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

Berelowitz M, Fischette C, Cefalu W, Schade DS, Sutfin T, Kourides IA.

Diabetes Care. 1994 Dec;17(12):1460-4.PMID: 7882817 [PubMed - indexed for MEDLINE]Related articles

The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.

Jaber LA, Ducharme MP, Edwards DJ, Slaughter RL, Grunberger G.

Pharmacotherapy. 1996 Sep-Oct;16(5):760-8.PMID: 8888072 [PubMed - indexed for MEDLINE]Related articles

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

Falko JM, Osei K.

Am J Med. 1985 Sep 20;79(3B):92-101.PMID: 3931467 [PubMed - indexed for MEDLINE]Related articles

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

Soneru IL, Agrawal L, Murphy JC, Lawrence AM, Abraira C.

Diabetes Care. 1993 Jun;16(6):896-901.PMID: 8325203 [PubMed - indexed for MEDLINE]Related articles

Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.

Goldstein BJ, Pans M, Rubin CJ.

Clin Ther. 2003 Mar;25(3):890-903.PMID: 12852706 [PubMed - indexed for MEDLINE]Related articles

Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.

Rosenstock J, Meisel A, Raskin P.

Am J Med. 1987 Sep 18;83(3A):10-5.PMID: 3307402 [PubMed - indexed for MEDLINE]Related articles